Related references
Note: Only part of the references are listed.Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms
Ming O. Li et al.
IMMUNITY (2006)
Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin
AR Yoon et al.
HUMAN GENE THERAPY (2006)
Recent progress in the battle between oncolytic viruses and tumours
KA Parato et al.
NATURE REVIEWS CANCER (2005)
ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis
CO Yun et al.
CANCER GENE THERAPY (2005)
Differential interactions of decorin and decorin mutants with type I and type VI collagens
G Nareyeck et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Regulatory approvals of pediatric oncology drugs: Previous experience and new initiatives
S Hirschfeld et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: Virus persists and spreads systemically at late time points
H Sauthoff et al.
HUMAN GENE THERAPY (2003)
Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy
J Kim et al.
CANCER GENE THERAPY (2002)
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
D Kirn et al.
NATURE MEDICINE (2001)
Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved - Deletion of the viral E1b-19-kD gene increases the viral oncolytic effect
D Harrison et al.
HUMAN GENE THERAPY (2001)
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
D Kirn
GENE THERAPY (2001)
Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy
N Kuriyama et al.
HUMAN GENE THERAPY (2000)
Cancer gene therapy: hard lessons and new courses
RG Vile et al.
GENE THERAPY (2000)
Share Paper
